Cargando…
The Pharmacologic Treatment of Stuttering and Its Neuropharmacologic Basis
Stuttering is a DSM V psychiatric condition for which there are no FDA-approved medications for treatment. A growing body of evidence suggests that dopamine antagonist medications are effective in reducing the severity of stuttering symptoms. Stuttering shares many similarities to Tourette’s Syndrom...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118465/ https://www.ncbi.nlm.nih.gov/pubmed/32292321 http://dx.doi.org/10.3389/fnins.2020.00158 |